Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.

Lal G, Groff M, Howe JR, Weigel RJ, Sugg SL, Lynch CF.

Ann Surg Oncol. 2012 Jun;19(6):1887-96. doi: 10.1245/s10434-011-2193-2. Epub 2012 Jan 7.

2.

Italian cancer figures, report 2013: Multiple tumours.

AIRTUM Working Group.

Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152. English, Italian.

3.

Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.

Abdel-Rahman O.

Clin Genitourin Cancer. 2017 Oct;15(5):e747-e754. doi: 10.1016/j.clgc.2017.02.004. Epub 2017 Feb 27.

PMID:
28314541
4.

Risk of thyroid malignancy following an index head and neck squamous cell carcinoma: A population-based study.

Chan JY, Gooi Z, Mydlarz WK, Agrawal N.

Ear Nose Throat J. 2016 Dec;95(12):E7-E11.

PMID:
27929600
5.

Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.

Balamurugan A, Rees JR, Kosary C, Rim SH, Li J, Stewart SL.

J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S69-77. doi: 10.1016/j.jaad.2011.04.033.

6.

Coupling of prostate and thyroid cancer diagnoses in the United States.

Tomaszewski JJ, Uzzo RG, Egleston B, Corcoran AT, Mehrazin R, Geynisman DM, Ridge JA, Veloski C, Kocher N, Smaldone MC, Kutikov A.

Ann Surg Oncol. 2015 Mar;22(3):1043-9. doi: 10.1245/s10434-014-4066-y. Epub 2014 Sep 10.

7.

Incidence of subsequent cholangiocarcinomas after another malignancy: trends in a population-based study.

Mao K, Jiang W, Liu J, Wang J.

Medicine (Baltimore). 2015 Feb;94(8):e596. doi: 10.1097/MD.0000000000000596.

8.

Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.

Hisada M, Chen BE, Jaffe ES, Travis LB.

J Natl Cancer Inst. 2007 Feb 7;99(3):215-22.

PMID:
17284716
9.

Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.

Werner-Wasik M, Schmid CH, Bornstein LE, Madoc-Jones H.

Cancer. 1995 May 1;75(9):2281-5.

10.

Risk of subsequent cancer following a primary CNS tumor.

Strodtbeck K, Sloan A, Rogers L, Fisher PG, Stearns D, Campbell L, Barnholtz-Sloan J.

J Neurooncol. 2013 Apr;112(2):285-95. doi: 10.1007/s11060-013-1063-0. Epub 2013 Feb 8.

11.

The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas.

Kim C, Bi X, Pan D, Chen Y, Carling T, Ma S, Udelsman R, Zhang Y.

Thyroid. 2013 May;23(5):575-82. doi: 10.1089/thy.2011.0406. Epub 2013 Apr 18.

12.

The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.

Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD.

J Clin Endocrinol Metab. 2008 Feb;93(2):504-15. Epub 2007 Nov 20.

PMID:
18029468
13.

Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui YY, Robison LL, Meadows AT, Kadan-Lottick NS.

J Clin Oncol. 2006 Jan 20;24(3):476-83.

PMID:
16421424
14.

Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study.

Murphy JD, Ma GL, Baumgartner JM, Madlensky L, Burgoyne AM, Tang CM, Martinez ME, Sicklick JK.

Cancer. 2015 Sep 1;121(17):2960-7. doi: 10.1002/cncr.29434. Epub 2015 Apr 30.

15.

Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?

Wu GX, Nelson RA, Kim JY, Raz DJ.

Clin Lung Cancer. 2017 Sep;18(5):543-550.e3. doi: 10.1016/j.cllc.2017.02.007. Epub 2017 Mar 2.

PMID:
28412093
16.

Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.

Khanal A, Budhathoki N, Singh VP, Shah BK.

Anticancer Res. 2017 Apr;37(4):2033-2036.

PMID:
28373478
17.

Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.

Cho YY, Lim J, Oh CM, Ryu J, Jung KW, Chung JH, Won YJ, Kim SW.

Cancer. 2015 Jan 15;121(2):259-68. doi: 10.1002/cncr.29025. Epub 2014 Sep 15.

18.

Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.

Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB.

J Clin Oncol. 2013 Oct 20;31(30):3807-14. doi: 10.1200/JCO.2013.50.3409. Epub 2013 Sep 16.

19.

The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database.

Anderson JK, Alanee S, Lindgren B, Slaton J.

Urol Oncol. 2013 Aug;31(6):862-5. doi: 10.1016/j.urolonc.2011.06.005. Epub 2011 Jul 23.

PMID:
21784673
20.

Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.

Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I.

Cancer. 2011 Oct 1;117(19):4439-46. doi: 10.1002/cncr.26070. Epub 2011 Mar 22.

Supplemental Content

Support Center